Format

Send to:

Choose Destination
See comment in PubMed Commons below
EMBO Mol Med. 2012 Jan;4(1):27-37. doi: 10.1002/emmm.201100185. Epub 2011 Dec 7.

Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice.

Author information

  • 1Yong Loo Lin School of Medicine, Department of Biochemistry, National University of Singapore, Singapore. guanghou_shui@nuhs.edu.sg

Abstract

Mycolic acids are attractive diagnostic markers for tuberculosis (TB) infection because they are bacteria-derived, contain information about bacterial species, modulate host-pathogen interactions and are chemically inert. Here, we present a novel approach based on mass spectrometry. Quantification of specific precursor → fragment transitions of approximately 2000 individual mycolic acids (MAs) resulted in high analytical sensitivity and specificity. We next used this tool in a retrospective case-control study of patients with pulmonary TB with varying disease burdens from South Korea, Vietnam, Uganda and South Africa. MAs were extracted from small volume sputum (200 µl) and analysed without the requirement for derivatization. Infected patients (70, 19 of whom were HIV+) could be separated from controls (40, 20 of whom were HIV+) with a sensitivity and specificity of 94 and 93%, respectively. Furthermore, we quantified MA species in lung tissue of TB-infected mice and demonstrated effective clearance of MA levels following curative rifampicin treatment. Thus, our results demonstrate for the first time the feasibility and clinical relevance of direct detection of mycobacterial lipids as biomarkers of TB infection.

Copyright © 2012 EMBO Molecular Medicine.

PMID:
22147526
[PubMed - indexed for MEDLINE]
PMCID:
PMC3376831
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk